HCA Healthcare EBITDA Margin 2012-2026 | HCA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for HCA Healthcare (HCA) over the last 10 years. The current EBITDA margin for HCA Healthcare as of March 31, 2026 is .
| HCA Healthcare EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-12-31 | $75.60B | $15.61B | 20.65% |
| 2025-09-30 | $74.37B | $15.21B | 20.44% |
| 2025-06-30 | $72.70B | $14.60B | 20.09% |
| 2025-03-31 | $71.59B | $14.30B | 19.97% |
| 2024-12-31 | $70.60B | $13.92B | 19.71% |
| 2024-09-30 | $69.62B | $13.82B | 19.85% |
| 2024-06-30 | $68.35B | $13.44B | 19.66% |
| 2024-03-31 | $66.72B | $12.94B | 19.40% |
| 2023-12-31 | $64.97B | $12.76B | 19.64% |
| 2023-09-30 | $63.16B | $12.32B | 19.51% |
| 2023-06-30 | $61.92B | $12.34B | 19.93% |
| 2023-03-31 | $60.88B | $12.33B | 20.25% |
| 2022-12-31 | $60.23B | $12.10B | 20.08% |
| 2022-09-30 | $59.80B | $12.07B | 20.18% |
| 2022-06-30 | $60.11B | $12.39B | 20.61% |
| 2022-03-31 | $59.72B | $12.56B | 21.03% |
| 2021-12-31 | $58.75B | $12.67B | 21.57% |
| 2021-09-30 | $57.98B | $12.64B | 21.80% |
| 2021-06-30 | $56.02B | $12.29B | 21.95% |
| 2021-03-31 | $52.65B | $10.92B | 20.74% |
| 2020-12-31 | $51.53B | $10.07B | 19.54% |
| 2020-09-30 | $50.76B | $9.69B | 19.08% |
| 2020-06-30 | $50.15B | $9.10B | 18.14% |
| 2020-03-31 | $51.68B | $9.55B | 18.47% |
| 2019-12-31 | $51.34B | $9.89B | 19.26% |
| 2019-09-30 | $50.09B | $9.66B | 19.28% |
| 2019-06-30 | $48.84B | $9.47B | 19.39% |
| 2019-03-31 | $47.77B | $9.40B | 19.68% |
| 2018-12-31 | $46.68B | $8.98B | 19.24% |
| 2018-09-30 | $45.97B | $8.83B | 19.22% |
| 2018-06-30 | $45.21B | $8.51B | 18.83% |
| 2018-03-31 | $44.41B | $8.38B | 18.86% |
| 2017-12-31 | $43.61B | $8.26B | 18.95% |
| 2017-09-30 | $42.69B | $8.11B | 18.99% |
| 2017-06-30 | $42.27B | $8.29B | 19.61% |
| 2017-03-31 | $41.85B | $8.25B | 19.72% |
| 2016-12-31 | $41.49B | $8.25B | 19.89% |
| 2016-09-30 | $41.10B | $8.18B | 19.90% |
| 2016-06-30 | $40.68B | $8.04B | 19.75% |
| 2016-03-31 | $40.26B | $7.99B | 19.85% |
| 2015-12-31 | $39.68B | $7.95B | 20.04% |
| 2015-09-30 | $39.07B | $7.78B | 19.91% |
| 2015-06-30 | $38.43B | $7.79B | 20.27% |
| 2015-03-31 | $37.76B | $7.78B | 20.61% |
| 2014-12-31 | $36.92B | $7.47B | 20.23% |
| 2014-09-30 | $36.12B | $7.23B | 20.03% |
| 2014-06-30 | $35.35B | $7.01B | 19.83% |
| 2014-03-31 | $34.57B | $6.71B | 19.40% |
| 2013-12-31 | $34.18B | $6.63B | 19.39% |
| 2013-09-30 | $33.78B | $6.53B | 19.32% |
| 2013-06-30 | $33.39B | $6.46B | 19.34% |
| 2013-03-31 | $33.05B | $6.34B | 19.18% |
| 2012-12-31 | $33.01B | $6.59B | 19.97% |
| 2012-09-30 | $32.35B | $6.62B | 20.47% |
| 2012-06-30 | $31.54B | $6.50B | 20.62% |
| 2012-03-31 | $30.68B | $6.36B | 20.72% |
| 2011-12-31 | $29.68B | $6.13B | 20.66% |
| 2011-09-30 | $27.72B | $5.95B | 21.45% |
| 2011-06-30 | $27.39B | $5.89B | 21.52% |
| 2011-03-31 | $27.90B | $5.97B | 21.38% |
| 2010-12-31 | $28.04B | $5.95B | 21.22% |
| 2010-09-30 | $26.56B | $5.84B | 22.01% |
| 2010-06-30 | $27.16B | $5.76B | 21.21% |
| 2010-03-31 | $26.89B | $5.67B | 21.08% |
| 2009-12-31 | $26.78B | $5.55B | 20.73% |
| 2009-09-30 | $29.71B | $5.45B | 18.33% |
| 2009-06-30 | $29.18B | $5.22B | 17.90% |
| 2009-03-31 | $28.68B | $4.93B | 17.18% |
| 2008-12-31 | $28.37B | $4.65B | 16.40% |
| 2008-09-30 | $27.99B | $4.63B | 16.53% |
| 2008-06-30 | $27.56B | $4.54B | 16.48% |
| 2008-03-31 | $27.31B | $4.60B | 16.83% |
| 2007-12-31 | $26.86B | $4.67B | 17.39% |
| 2007-09-30 | $26.46B | $4.73B | 17.87% |
| 2007-06-30 | $26.11B | $4.66B | 17.86% |
| 2007-03-31 | $25.74B | $4.56B | 17.72% |
| 2006-12-31 | $25.48B | $4.49B | 17.62% |
| 2006-09-30 | $25.17B | $4.21B | 16.73% |
| 2006-06-30 | $24.98B | $4.24B | 16.98% |
| 2006-03-31 | $24.69B | $4.28B | 17.35% |
| 2005-12-31 | $24.46B | $4.28B | 17.51% |
| 2005-09-30 | $24.22B | $4.27B | 17.65% |
| 2005-06-30 | $23.98B | $4.20B | 17.52% |
| 2005-03-31 | $23.75B | $4.14B | 17.41% |
| 2004-12-31 | $23.50B | $3.97B | 16.88% |
| 2004-09-30 | $23.16B | $3.87B | 16.71% |
| 2004-06-30 | $22.84B | $3.93B | 17.20% |
| 2004-03-31 | $22.47B | $3.85B | 17.12% |
| 2003-12-31 | $21.81B | $3.92B | 17.98% |
| 2003-09-30 | $21.24B | $3.94B | 18.54% |
| 2003-06-30 | $20.69B | $3.92B | 18.94% |
| 2003-03-31 | $20.13B | $3.97B | 19.71% |
| 2002-12-31 | $19.73B | $3.90B | 19.77% |
| 2002-09-30 | $19.24B | $3.78B | 19.65% |
| 2002-06-30 | $18.75B | $3.63B | 19.38% |
| 2002-03-31 | $18.33B | $3.49B | 19.06% |
| 2001-12-31 | $17.95B | $3.42B | 19.06% |
| 2001-09-30 | $17.59B | $3.35B | 19.07% |
| 2001-06-30 | $17.24B | $3.32B | 19.25% |
| 2001-03-31 | $16.90B | $3.24B | 19.19% |
| 2000-12-31 | $16.67B | $3.18B | 19.06% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $110.772B | $75.600B |
| HCA Healthcare Inc. is a provider of healthcare services comprising hospitals and ambulatory sites of care including surgery centers, freestanding ERs, urgent care centers and physician clinics. HCA Healthcare Inc., formerly known as HCA HOLDINGS, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Cencora (COR) | United States | $62.409B | 19.63 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |